Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2022-07-19 00:00:00 ET · period of report 2022-07-15 · accession 0000899243-22-026345 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-19 | 2022-07-15 | ALDX | Greenberg Bruce | See Remarks | A - Grant | $0.00 | +126.1K | 133.9K | +1,614% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-15 | A | A | 126,087 | $0.00 | 133,900 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on July 15, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. |